Literature DB >> 8114001

P2Y purinoceptor and nucleotide receptor-induced relaxation of precontracted bovine aortic collateral artery rings: differential sensitivity to suramin and indomethacin.

G F Wilkinson1, K McKechnie, I A Dainty, M R Boarder.   

Abstract

We have examined a series of adenine nucleotides and UTP for their ability to cause relaxation of precontracted bovine aortic collateral artery rings. The overall rank order of agonist potency for relaxation was 2-methylthioadenosine 5'-triphosphate (2MeSATP) > adenosine 5'-O-(3-thiotriphosphate) (ATP gamma S) > UTP > ADP > ATP. These responses were endothelium-dependent. Interaction studies showed that responses to the selective P2Y purinoceptor agonist 2MeSATP, and to ADP, were mediated by different receptors from those mediating responses to UTP. Suramin, a P2 purinoceptor antagonist that binds to diverse sites for ATP, produced a concentration-dependent shift in the agonist concentration-effect curve to 2MeSATP, with a pKB of 5.45 +/- 0.15 and a slope of 0.94 +/- 0.09. Suramin produced a small, nonsignificant shift in the UTP response curve and had little effect on responses to ATP. Indomethacin (2.8 x 10(-6) M) had no effect on concentration-effect curves to UTP but almost abolished the relaxations produced by 2MeSATP and ADP. The concentration-effect curves to ATP and ATP gamma S showed a significant (P < .05) rightward shift in the presence of indomethacin. These results suggest the presence of separate P2Y purinoceptor and nucleotide receptors mediating endothelium-dependent relaxations of bovine aortic collateral artery smooth muscle. ATP acts at both receptors, whereas ADP acts at only one (P2Y). The effects of indomethacin show that these receptors differentially modulate the release of cyclooxygenase-derived mediators of relaxation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8114001

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  Responses of the longitudinal muscle and the muscularis mucosae of the rat duodenum to adenine and uracil nucleotides.

Authors:  C R Johnson; S J Charlton; S M Hourani
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

2.  A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.

Authors:  C Ho; J Hicks; M W Salter
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors.

Authors:  S J Charlton; C A Brown; G A Weisman; J T Turner; L Erb; M R Boarder
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 4.  The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.

Authors:  Guido Beldi; Keiichi Enjyoji; Yan Wu; Lindsay Miller; Yara Banz; Xiaofeng Sun; Simon C Robson
Journal:  Front Biosci       Date:  2008-01-01

5.  Actions of ADP, but not ATP, on cytosolic free Ca2+ in single rat hepatocytes mimicked by 2-methylthioATP.

Authors:  C J Dixon; P H Cobbold; A K Green
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

6.  Evidence for a P2-purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat.

Authors:  A Rubino; G Burnstock
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

7.  PPADS: an antagonist at endothelial P2Y-purinoceptors but not P2U-purinoceptors.

Authors:  C Brown; B Tanna; M R Boarder
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

8.  Evidence for requirement of tyrosine phosphorylation in endothelial P2Y- and P2U- purinoceptor stimulation of prostacyclin release.

Authors:  A Bowden; V Patel; C Brown; M R Boarder
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

9.  Extracellular ATP binding proteins as potential receptors in mucociliary epithelium: characterization using [32P]3'-O-(4-benzoyl)benzoyl ATP, a photoaffinity label.

Authors:  L Gheber; Z Priel; C Aflalo; V Shoshan-Barmatz
Journal:  J Membr Biol       Date:  1995-09       Impact factor: 1.843

10.  Inhibitory action of PPADS on relaxant responses to adenine nucleotides or electrical field stimulation in guinea-pig taenia coli and rat duodenum.

Authors:  U Windscheif; O Pfaff; A U Ziganshin; C H Hoyle; H G Bäumert; E Mutschler; G Burnstock; G Lambrecht
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.